Search Results

There are 10694 results for: content related to: Review article: infliximab therapy for inflammatory bowel disease – seven years on

  1. Infliximab for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Barbara BTB Blumenauer, Maria Judd, George A Wells, Amanda Burls, Ann Cranney, Marc C Hochberg, Peter Tugwell and Maria Angeles Lopez-Olivo

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD003785

  2. Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 7, October 2016, Pages: 673–683, T. Billiet, I. Cleynen, V. Ballet, M. Ferrante, G. Van Assche, A. Gils and S. Vermeire

    Version of Record online : 9 AUG 2016, DOI: 10.1111/apt.13754

  3. You have free access to this content
    TNF-alpha inhibitors for ankylosing spondylitis

    Intervention Review

    The Cochrane Library

    Lara J Maxwell, Jane Zochling, Annelies Boonen, Jasvinder A Singh, Mirella MS Veras, Elizabeth Tanjong Ghogomu, Maria Benkhalti Jandu, Peter Tugwell and George A Wells

    Published Online : 18 APR 2015, DOI: 10.1002/14651858.CD005468.pub2

  4. Infliximab

    Dermatologic Therapy

    Volume 17, Issue 5, October 2004, Pages: 409–426, Laura S. Winterfield and Alan Menter

    Version of Record online : 20 SEP 2004, DOI: 10.1111/j.1396-0296.2004.04044.x

  5. You have free access to this content
    Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials

    Alimentary Pharmacology & Therapeutics

    Volume 30, Issue 3, August 2009, Pages: 210–226, G. R. LICHTENSTEIN, R. H. DIAMOND, C. L. WAGNER, A. A. FASANMADE, A. D. OLSON, C. W. MARANO, J. JOHANNS, Y. LANG and W. J. SANDBORN

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1365-2036.2009.04027.x

  6. You have free access to this content
    Systematic review: infliximab therapy in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 1, January 2007, Pages: 19–37, J. P. GISBERT, Y. GONZÁLEZ-LAMA and J. MATÉ

    Version of Record online : 6 DEC 2006, DOI: 10.1111/j.1365-2036.2006.03131.x

  7. You have free access to this content
    Practical application of anti-TNF therapy for luminal Crohn's disease

    Inflammatory Bowel Diseases

    Volume 17, Issue 11, November 2011, Pages: 2366–2391, Michael A. Kamm, Siew C. Ng, Peter De Cruz, Patrick Allen and Stephen B. Hanauer

    Version of Record online : 18 FEB 2011, DOI: 10.1002/ibd.21655

  8. You have free access to this content
    Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 118–128, David Ternant, Emilie Ducourau, Aleth Perdriger, Anca Corondan, Benoît Le Goff, Valérie Devauchelle-Pensec, Elisabeth Solau-Gervais, Hervé Watier, Philippe Goupille, Gilles Paintaud and Denis Mulleman

    Version of Record online : 20 JUN 2014, DOI: 10.1111/bcp.12313

  9. You have free access to this content
    Tumor Necrosis Factor Alpha Inhibitors as Immunomodulatory Antirejection Agents after Intestinal Transplantation

    American Journal of Transplantation

    Volume 11, Issue 5, May 2011, Pages: 1041–1050, U. A. Gerlach, M. Koch, H.-P. Müller, W. Veltzke-Schlieker, P. Neuhaus and A. Pascher

    Version of Record online : 26 APR 2011, DOI: 10.1111/j.1600-6143.2011.03497.x

  10. You have free access to this content
    The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 46, Issue 6, June 2002, Pages: 1451–1459, E. William St.Clair, Carrie L. Wagner, Adedigbo A. Fasanmade, Benjamin Wang, Thomas Schaible, Arthur Kavanaugh and Edward C. Keystone

    Version of Record online : 6 JUN 2002, DOI: 10.1002/art.10302

  11. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

    Intervention Review

    The Cochrane Library

    Brian W Behm and Stephen J Bickston

    Published Online : 23 JAN 2008, DOI: 10.1002/14651858.CD006893

  12. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease

    Intervention Review

    The Cochrane Library

    Nilesh Chande, Cassandra M Townsend, Claire E Parker and John K MacDonald

    Published Online : 26 OCT 2016, DOI: 10.1002/14651858.CD000545.pub5

  13. Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 838–848, John Paul Leombruno, Geoffrey C. Nguyen, Paul Grootendorst, David Juurlink and Tom Einarson

    Version of Record online : 17 JUN 2011, DOI: 10.1002/pds.2132

  14. You have free access to this content
    Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

    Arthritis & Rheumatism

    Volume 50, Issue 11, November 2004, Pages: 3432–3443, E. William St. Clair, Désirée M. F. M. van der Heijde, Josef S. Smolen, Ravinder N. Maini, Joan M. Bathon, Paul Emery, Edward Keystone, Michael Schiff, Joachim R. Kalden, Ben Wang, Kimberly DeWoody, Roberta Weiss, Daniel Baker and Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group

    Version of Record online : 4 NOV 2004, DOI: 10.1002/art.20568

  15. You have free access to this content
    Costs of care for Crohn’s disease following the introduction of infliximab: a single-centre UK experience

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 11-12, December 2010, Pages: 1357–1363, M. B. Sprakes, A. C. Ford, N. C. Suares, L. Warren, D. Greer, C. F. Donnellan, J. S. R. Jennings, S. M. Everett and P. J. Hamlin

    Version of Record online : 6 OCT 2010, DOI: 10.1111/j.1365-2036.2010.04482.x

  16. Infliximab dependency in pediatric Crohn's disease: Long-term follow-up of an unselected cohort

    Inflammatory Bowel Diseases

    Volume 14, Issue 3, March 2008, Pages: 353–358, Lissy de Ridder, Edmond H.H.M. Rings, Gerard M. Damen, C.M. Frank Kneepkens, Joachim J. Schweizer, Freddy T.M. Kokke, Marc A. Benninga, Obbe F. Norbruis, J. Hans Hoekstra, Carolien F.M. Gijsbers and Johanna C. Escher

    Version of Record online : 10 DEC 2007, DOI: 10.1002/ibd.20329

  17. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis

    Intervention Review

    The Cochrane Library

    Maureen M Lawson, Adrian G Thomas and Anthony K Akobeng

    Published Online : 19 JUL 2006, DOI: 10.1002/14651858.CD005112.pub2

  18. Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 6, November 2004, Pages: 801–810, Mihaela Ringheanu, Fredric Daum, James Markowitz, Jeremiah Levine, Seymour Katz, Xingyu Lin and Jack Silver

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200411000-00015

  19. You have free access to this content
    Infliximab for refractory ulcerative proctitis

    Alimentary Pharmacology & Therapeutics


    Version of Record online : 8 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04293.x

  20. Crohn's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt019